Analisis Keuangan Saham 1EXAS - Exact Sciences Corporation (BIT) Stock

Exact Sciences Corporation
IT ˙ BIT ˙ US30063P1057
€ 45.32 ↑5.07 (12.59%)
2025-09-05
BAHAGING PRESYO
Gambaran Umum
Exact Sciences Corporation, based in the United States, operates primarily in the diagnostics and research industry focusing significantly on the detection and prevention of cancer. It is renowned for developing Cologuard, an FDA-approved non-invasive stool DNA screening test for colorectal cancer. The company is also expanding its portfolio through innovation and acquisitions, such as its purchase of molecular diagnostics company Genomic Health, enhancing its capabilities in cancer genetics and precision oncology. Additionally, Exact Sciences is advancing in the development of multi-cancer screening technologies that aim to detect various types of cancer from a single blood sample, positioning the company at the forefront of cancer diagnostics research and applications.
Skor Kualitas, Nilai, dan Momentum

Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.

Kualitas

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Nilai

Model penilaian eksklusif yang memberi peringkat pada perusahaan berdasarkan valuasi relatifnya. Skor berkisar antara 0 hingga 100, dengan 100 sebagai yang paling diremehkan nilainya.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Sentimen Dana

Skor Sentimen Dana (sebelumnya dikenal sebagai Skor Kepemilikan) adalah model kuantitatif eksklusif yang memberi peringkat pada perusahaan berdasarkan tingkat akumulasi kepemilikan.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
  • Nilai revenue untuk Exact Sciences Corporation per 2025 Jun 30 adalah 2,939.95 MM.
  • Nilai operating income untuk Exact Sciences Corporation per 2025 Jun 30 adalah -138.98 MM.
  • Nilai net income untuk Exact Sciences Corporation per 2025 Jun 30 adalah -1,005.22 MM.
Period End (TTM) Revenue (MM) Operating Income (MM) Net Income (MM)
2025-06-30 2,939.95 -138.98 -1,005.22
2025-03-31 2,828.13 -176.88 -1,019.84
2024-12-31 2,758.87 -191.79 -1,028.86
2024-09-30 2,692.33 -227.22 -214.04
2024-06-30 2,612.01 -282.27 -175.01
2024-03-31 2,534.84 -319.25 -240.23
2023-12-31 2,499.77 -308.83 -204.15
2023-09-30 2,405.88 -346.08 -282.13
2023-06-30 2,300.61 -397.26 -431.68
2023-03-31 2,200.16 -503.21 -516.72
2022-12-31 2,084.28 -634.16 -623.51
2022-09-30 2,005.10 -722.36 -716.37
2022-06-30 1,938.40 -729.34 -734.55
2022-03-31 1,851.58 -709.51 -745.40
2021-12-31 1,767.09 -710.57 -595.62
2021-09-30 1,759.61 -887.92 -793.35
2021-06-30 1,711.60 -749.88 -828.95
2021-03-31 1,545.65 -682.31 -720.13
2020-12-31 1,491.39 -581.70 -823.61
2020-09-30 1,320.63 -200.00 -327.30
Laporan Laba Rugi: EPS
Period End (TTM) Earnings Per Share Basic Earnings Per Share Diluted
2025-06-30
2025-03-31 -5.50 -5.51
2024-12-31 -5.59 -5.59
2024-09-30 -1.17 -1.16
2024-06-30 -0.96 -0.95
2024-03-31 -1.33 -1.32
2023-12-31 -1.13 -1.13
2023-09-30 -1.57 -1.57
2023-06-30 -2.42 -2.42
2023-03-31 -2.91 -2.91
2022-12-31 -3.54 -3.54
2022-09-30 -4.09 -4.09
2022-06-30 -4.23 -4.23
2022-03-31 -4.32 -4.33
2021-12-31 -3.48
2021-09-30 -4.74 -4.74
2021-06-30 -5.12 -5.12
2021-03-31 -4.60 -4.60
2020-12-31 -5.45
2020-09-30 -2.23 -2.23
Arus Kas: Operasi, Investasi, Pendanaan
  • Nilai cash from operating activities untuk Exact Sciences Corporation per 2025 Jun 30 adalah 305.61 MM.
  • Nilai cash from investing activities untuk Exact Sciences Corporation per 2025 Jun 30 adalah 66.87 MM.
  • Nilai kas dari aktivitas pendanaan untuk Exact Sciences Corporation per 2025 Jun 30 adalah -250.41 MM.
Period End (TTM) Cash From Operating Activities (MM) Cash From Investing Activities (MM) Cash From Financing Activities (MM)
2025-06-30 305.61 66.87 -250.41
2025-03-31 323.66 -305.15 -21.30
2024-12-31 210.54 -442.15 231.87
2024-09-30 233.02 -467.05 231.41
2024-06-30 118.66 -418.30 231.73
2024-03-31 112.02 -204.70 23.17
2023-12-31 156.12 49.68 159.77
2023-09-30 138.61 58.29 159.83
2023-06-30 73.32 156.26 159.97
2023-03-31 -88.02 111.45 207.35
2022-12-31 -223.56 74.07 76.48
2022-09-30 -300.17 210.66 54.19
2022-06-30 -300.02 96.41 54.03
2022-03-31 -198.76 -719.01 3.96
2021-12-31 -102.24 -1,082.09 8.47
2021-09-30 33.74 -1,467.16 900.53
2021-06-30 156.29 -1,401.09 904.60
2021-03-31 109.08 -613.70 907.39
2020-12-31 136.48 -702.04 1,879.62
2020-09-30 -0.22 -1,233.53 1,006.39
Metrik Penilaian: PE, PriceToBook, PriceToTBV
P/Book
The current closing price divided by the book value per share.
P/TBV
The current price divided by the tangible book value per share.
Period End (TTM) p/e P/Book P/TBV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) EBIT/EV EBIT (3y)/EV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
Efektivitas Manajemen
  • roa untuk Exact Sciences Corporation pada 2025 Jun 30 adalah -0.15.
  • roe untuk Exact Sciences Corporation pada 2025 Jun 30 adalah -0.31.
  • roic untuk Exact Sciences Corporation pada 2025 Jun 30 adalah -0.20.
  • croic untuk Exact Sciences Corporation pada 2025 Jun 30 adalah -0.00.
  • ocroic untuk Exact Sciences Corporation pada 2025 Jun 30 adalah 0.06.
Period End (TTM) ROA ROE ROIC (Tingkat Pengembalian Investasi Modal) CROIC OCROIC
2025-06-30 -0.15 -0.31 -0.20 -0.00 0.06
2025-03-31 -0.16 -0.33 -0.20 -0.00 0.06
2024-12-31 -0.03 -0.07 -0.04 -0.00 0.04
2024-09-30 -0.03 -0.07 -0.04 -0.00 0.04
2024-06-30 -0.04 -0.08 -0.04 -0.01 0.02
2024-03-31 -0.03 -0.07 -0.04 0.06 0.03
2023-12-31 -0.04 -0.09 -0.05 0.06 0.02
2023-09-30 -0.07 -0.13 -0.08 0.07 0.01
2023-06-30 -0.07 -0.13 -0.08 0.07 0.01
2023-03-31 -0.08 -0.16 -0.09 0.04 -0.02
2022-12-31 -0.11 -0.21 -0.13 -0.01 -0.05
2022-09-30 -0.11 -0.21 -0.13 -0.01 -0.05
2022-06-30 -0.11 -0.21 -0.13 -0.03 -0.05
2022-03-31 -0.11 -0.20 -0.12 -0.15 -0.03
2021-12-31 -0.12 -0.27 -0.10 -0.19 -0.02
2021-09-30 -0.19 -0.35 -0.14 -0.09 0.01
2021-06-30 -0.19 -0.34 -0.14 -0.06 0.03
2021-03-31 -0.16 -0.28 -0.12 0.07 0.02
2020-12-31 -0.23 -0.36 -0.18 0.29 0.03
2020-09-30 -0.20 -0.46 -0.08 -0.06 -0.00
Gross Margins
  • marjin kotor untuk Exact Sciences Corporation pada 2025 Jun 30 adalah 0.70.
  • marjin bersih untuk Exact Sciences Corporation pada 2025 Jun 30 adalah -0.36.
  • marjin operasi untuk Exact Sciences Corporation pada 2025 Jun 30 adalah -0.07.
Margin Kotor
The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
Margin Keuntungan Bersih
Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
Margin Operasi
Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) Margin Kotor Margin Keuntungan Bersih Margin Operasi
2025-06-30 0.70 -0.36 -0.07
2025-03-31 0.70 -0.36 -0.07
2024-12-31 0.73 -0.08 -0.08
2024-09-30 0.73 -0.08 -0.08
2024-06-30 0.74 -0.09 -0.13
2024-03-31 0.74 -0.08 -0.09
2023-12-31 0.74 -0.12 -0.16
2023-09-30 0.74 -0.19 -0.20
2023-06-30 0.74 -0.19 -0.20
2023-03-31 0.73 -0.23 -0.24
2022-12-31 0.73 -0.36 -0.36
2022-09-30 0.73 -0.36 -0.36
2022-06-30 0.73 -0.38 -0.38
2022-03-31 0.74 -0.40 -0.38
2021-12-31 0.74 -0.34 -0.39
2021-09-30 0.75 -0.47 -0.50
2021-06-30 0.76 -0.50 -0.43
2021-03-31 0.75 -0.47 -0.44
2020-12-31 0.76 -0.55 -0.39
2020-09-30 0.75 -0.26 -0.15
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK)1124140
Grupong Pang-industriya
SIC 8071 - Medical Laboratories
Other Listings
MX:EXAS
DE:EXK € 43.87
US:EXAS US$ 53.81
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista